Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma.
about
Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classificationSpecific recommendations for accurate and direct use of PET-CT in PET guided radiotherapy for head and neck sites.Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's LymphomaCombination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL.Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.Evaluation of Cross-Calibrated 68Ge/68Ga Phantoms for Assessing PET/CT Measurement Bias in Oncology Imaging for Single- and Multicenter TrialsPET/CT adapted therapy in Hodgkin disease: current state of the art and future directions.The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma.When should FDG-PET be used in the modern management of lymphoma?WIDEN: A tool for medical image management in multicenter clinical trials.FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials.Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma.Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.The Strategies to Homogenize PET/CT Metrics: The Case of Onco-Haematological Clinical Trials.
P2860
Q34495333-223B61AC-78AA-4878-A8D5-8CE7FE203C2BQ34663865-3CC0E9E1-EA41-44DB-B540-199C4E53E53BQ35138065-C314A6A7-98AC-4B19-A583-6E7F80AC6D68Q35952736-23333482-36DB-445A-8D36-03C2BF70E720Q36897012-58CEE1DC-0787-467B-8D1E-044B86FC554BQ37126978-E25E0322-FCF1-4B4C-AADB-C8EFE7A8D25DQ37240835-7F860EFE-B9C0-4957-A2B4-4F429B1257FAQ37558197-BA00D076-D4FE-425B-BDE4-BC4FBE3C034BQ38018865-455C7D3E-C211-4512-B98E-CCD6558468EFQ38110318-FDBEC3A7-01BC-4E2C-8FD6-F6E70E789F01Q38153086-5D4B26A3-C9AC-47DC-B94C-1ADD156C9600Q38202946-0B0B19AD-B843-40A0-BACB-4376ACD2FF51Q38836081-2DA8D111-164C-45D6-9231-F3BD8EF2834FQ38932290-D338BA3A-0FF7-4A7B-A6E2-E406B19A3867Q40635561-A096DB1E-7BFC-4003-8AB6-9E305B23A3F1Q44307668-3B4FC97A-1DBD-4E19-B75D-0EBFA279DAA5Q49827199-F888336C-FDDB-480F-AC72-3C5B1E610A5DQ53011053-0B386503-78DB-4576-A6DB-45A2BF8A5F4FQ54152231-DF49F4D1-398E-42F0-B9A3-05D1F551B189
P2860
Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Establishment of a UK-wide net ...... r clinical trials in lymphoma.
@ast
Establishment of a UK-wide net ...... r clinical trials in lymphoma.
@en
type
label
Establishment of a UK-wide net ...... r clinical trials in lymphoma.
@ast
Establishment of a UK-wide net ...... r clinical trials in lymphoma.
@en
prefLabel
Establishment of a UK-wide net ...... r clinical trials in lymphoma.
@ast
Establishment of a UK-wide net ...... r clinical trials in lymphoma.
@en
P2093
P50
P356
P1433
P1476
Establishment of a UK-wide net ...... r clinical trials in lymphoma.
@en
P2093
J E Mackewn
M J O'Doherty
N G Mikhaeel
P K Marsden
P Schleyer
S F Barrington
P304
P356
10.1093/ANNONC/MDQ428
P577
2010-09-02T00:00:00Z